Information Provided By:
Fly News Breaks for June 5, 2018
AMED
Jun 5, 2018 | 07:54 EDT
Oppenheimer analyst Michael Wiederhorn raised his price target for Amedisys to $85 from $77 on 6%-7% accretive share repurchase. The analyst reiterates an Outperform rating on the shares.
News For AMED From the Last 2 Days
There are no results for your query AMED